Ophthalmology
Shaping the future of vision care through science and innovation. At Innoclin Research, we understand that eye diseases can drastically impair quality of life, independence, and productivity. From widespread disorders like glaucoma, cataracts, and diabetic retinopathy to rare inherited retinal diseases, our mission is to deliver clinical trials that preserve and restore sight through safe, effective, and innovative therapies.
Comprehensive approaches for complex eye disorders
Ophthalmology study require precision. We integrate advanced techniques, biomarker-driven endpoints, and tele-ophthalmology platforms to accurately assess disease progression and treatment response. By partnering with leading eye care centers and retinal specialists worldwide, we ensure studies are conducted with both scientific rigor and patient accessibility in mind.
Enhancing patient accessibility and adherence
Patients with vision impairment often face barriers to study participation. Our decentralized and hybrid trial models include remote vision assessments, portable diagnostic tools, and support services for mobility-impaired participants. These solutions improve recruitment, retention, and the overall patient experience while ensuring the collection of reliable, real-world data.
Regulatory pathways for novel eye therapies
Eye care research increasingly involves cutting-edge therapies such as gene therapy, stem cell–based treatments, and sustained-release drug delivery systems. Our regulatory specialists bring experience navigating approvals for these advanced modalities, ensuring that sponsors can move from early clinical phases to market authorization smoothly and efficiently.
We bring knowledge from across therapeutic areas to strengthen eye research:
Endocrinology
Advancing studies in diabetic eye disease and endocrine-related vision loss.
Neurology
Investigating neuro-ophthalmic conditions involving the optic nerve and brain pathways.
Pediatrics
Designing protocols for congenital and childhood eye disorders.
